CMV-SpyCas9 Citations (2)
Originally described in: Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.Bubeck F, Hoffmann MD, Harteveld Z, Aschenbrenner S, Bietz A, Waldhauer MC, Borner K, Fakhiri J, Schmelas C, Dietz L, Grimm D, Correia BE, Eils R, Niopek D Nat Methods. 2018 Oct 30. pii: 10.1038/s41592-018-0178-9. doi: 10.1038/s41592-018-0178-9. PubMed Journal
Articles Citing CMV-SpyCas9
| Articles |
|---|
Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD, Aschenbrenner S, Grosse S, Rapti K, Domenger C, Fakhiri J, Mastel M, Borner K, Eils R, Grimm D, Niopek D.
Nucleic Acids Res. 2019 Apr 15. pii: 5458120. doi: 10.1093/nar/gkz271.
PubMed
Associated Plasmids |
| A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins. Gama-Brambila RA, Chen J, Dabiri Y, Tascher G, Nemec V, Munch C, Song G, Knapp S, Cheng X. JACS Au. 2021 May 12;1(6):777-785. doi: 10.1021/jacsau.1c00007. eCollection 2021 Jun 28. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.